Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2009-11-02 Report Publication Anno…
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG Q3 Conference Call and Webcast
Report Publication Announcement Classification · 99% confidence The document explicitly announces a 'Q3 Conference Call and Webcast' scheduled for November 6, 2009, to discuss the financial results for the third quarter. This is an announcement about an upcoming event where financial results will be discussed, which aligns perfectly with the definition of a Call Transcript (CT) if the full transcript were present, or more accurately, an announcement leading up to an earnings call. Since the text details the date, time, dial-in numbers, and purpose (informing about financial results), it is an announcement related to an earnings call. Among the provided codes, 'CT' (Call Transcript) is the closest fit for content related to an earnings call, although this specific document is the *announcement* of the call, not the transcript itself. However, given the options, documents announcing earnings calls are often grouped with earnings-related materials. If 'RPA' (Report Publication Announcement) were used, it would typically be for announcing the release of a formal report (like the 10-Q or ER). Since this is specifically about the *call* discussing the results, and it is not the actual Earnings Release (ER) or the full Interim Report (IR), the most relevant category related to the event is 'CT'. Given the 'Menu vs Meal' rule, this is an announcement *about* the call, not the transcript itself. Therefore, 'RPA' (Report Publication Announcement) or 'RNS' (Regulatory Filings) might be considered. However, because the core subject is the conference call where results are discussed, and 'CT' is the category for conference calls, I will classify it as the announcement of the call event. Since it is an announcement about an event where financial results are discussed, and it is not the formal ER, I will lean towards 'RPA' as it announces the event/presentation, or 'CT' as the subject matter. Given the structure, it is an announcement of an event, making RPA plausible, but since the event is a conference call, CT is also strongly implied. I will select CT as the primary subject matter is the conference call itself, even though this is the invitation/notice.
2009-11-02 English
Declaration of Voting Results & Voting Rights Announcements 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text explicitly states 'Voting Rights Announcements' in the header and details a notification from Deutsche Bank AG regarding the percentage of voting rights crossing below a threshold (3%) according to German Securities Trading Act (§ 21 Abs. 1, 24 WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'.
2009-10-30 English
4SC AG Announces Capital Increase
Capital/Financing Update Classification · 98% confidence The document is titled '4SC AG Announces Capital Increase' and explicitly states it is an 'Ad hoc announcement in accordance with §15 WpHG'. The content details a decision by the Management Board to increase the company's share capital through the issue of new shares, including subscription prices and timelines. This action directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is an ad-hoc announcement, the core subject matter is the capital change itself, making CAP more specific than a general RPA or RNS.
2009-10-23 English
4SC presents clinical and preclinical data on its histone deacetylase (HDAC) inhibitor 4SC-201 at the ECCO - ESMO Cancer Conference
Regulatory Filings Classification · 100% confidence The document is a press release dated September 18, 2009, announcing that 4SC AG will present clinical and preclinical data on its drug candidate 4SC-201 at the ECCO - ESMO Cancer Conference. It details the abstract number, session time, and content of the presentation. This type of announcement, which publicizes upcoming scientific presentations or data disclosures, is best classified as a general Investor Presentation (IP) or, given its nature as a broad corporate news item about scientific progress, it fits well under the general category of Investor Presentation, as it is designed to inform investors about ongoing R&D milestones. However, since it is a press release announcing participation in a conference rather than the presentation material itself, and it is not a formal earnings release (ER) or a comprehensive interim report (IR), it functions as a general corporate update. Given the options, 'Investor Presentation' (IP) is the closest fit for disseminating detailed scientific/clinical progress to the investment community, although 'Regulatory Filings' (RNS) is a possible fallback if the content were less focused on investment-relevant data dissemination. Since it is a detailed announcement about clinical data presentation, IP is the most specific fit among the choices for communicating R&D milestones to investors.
2009-09-18 English
4SC AG:Investor Conferences
Report Publication Announcement Classification · 99% confidence The document is a short press release titled "4SC AG:Investor Conferences" announcing that company executives will be presenting updates on strategy, programs, and prospects at upcoming investor conferences (Sal. Oppenheim, Rodman & Renshaw, and DZ Bank). This content is an announcement about future investor engagement and presentations, not the presentation itself, a formal financial report (like 10-K or IR), or a transcript. It fits best under the category of general investor relations communication, specifically announcing participation in investor events, which aligns closely with Investor Presentation (IP) or, given its nature as a brief announcement about future events, potentially a Regulatory Filing (RNS) if a more specific category isn't available. However, since it details *where* and *when* management will present strategic updates, it is most closely related to the content shared in an Investor Presentation (IP). Given the options, and since it is an announcement about management presenting company information to investors, IP is the most suitable fit, although RPA (Report Publication Announcement) is also a possibility if this were announcing a formal report. Since it announces management presentations, IP is chosen.
2009-08-26 English
4SC Commences Phase II trial in Hepatocellular Carcinoma (HCC) with the HDAC Inhibitor 4SC-201
Regulatory Filings Classification · 100% confidence The document is a press release from 4SC AG announcing the commencement of a Phase II clinical trial for their drug 4SC-201 in Hepatocellular Carcinoma (HCC). It details the study design, endpoints, and provides commentary from investigators and management. This content is characteristic of a corporate update regarding clinical development progress, which falls under the general category of investor relations or corporate news. Since it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR), and it is a detailed update rather than just a brief announcement of a report (RPA/RNS), the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a general corporate announcement, or potentially 'LTR' if it were about legal proceedings, but here it is about research. Given the options, and that it is a news release about company operations/research, RNS serves as the best general corporate news/regulatory announcement fallback, although it is highly specific operational news. However, looking closely at the definitions, none perfectly capture a 'Clinical Trial Commencement Announcement'. Since it is a formal news release transmitted by DGAP (a common channel for regulatory/corporate news), and it is not a financial report, 'RNS' (Regulatory Filings / General regulatory announcements) is the most suitable catch-all for specific operational news that isn't explicitly defined elsewhere.
2009-08-18 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.